Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL—a report from the EBMT registry
Bone Marrow Transplantation, Published online: 09 January 2024; doi:10.1038/s41409-023-02192-0Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL—a report from the EBMT registry
Source: Bone Marrow Transplantation - Category: Hematology Authors: A. Sadowska-Klasa J. M. Zaucha M. Labopin J. H. Bourhis D. Blaise I. Yakoub-Agha U. Salmenniemi J. Passweg N. Fegueux T. Schroeder S. Giebel E. Brissot F. Ciceri M. Mohty Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Bone Marrow Transplant | Hematology | Leukemia | Transplants